Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Relation of sensory peripheral neuropathy in Sjögren syndrome to anti-Ro/SSA.

Scofield AK, Radfar L, Ice JA, Vista E, Anaya JM, Houston G, Lewis D, Stone DU, Chodosh J, Hefner K, Lessard CJ, Moser KL, Scofield RH.

J Clin Rheumatol. 2012 Sep;18(6):290-3.

2.

Peripheral neuropathies associated with primary Sjögren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy.

Sène D, Jallouli M, Lefaucheur JP, Saadoun D, Costedoat-Chalumeau N, Maisonobe T, Diemert MC, Musset L, Haroche J, Piette JC, Amoura Z, Cacoub P.

Medicine (Baltimore). 2011 Mar;90(2):133-8. doi: 10.1097/MD.0b013e31820fd2d1.

4.
5.
6.

Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.

Kurien BT, Dsouza A, Igoe A, Lee YJ, Maier-Moore JS, Gordon T, Jackson M, Scofield RH.

Clin Exp Immunol. 2013 Jul;173(1):67-75. doi: 10.1111/cei.12094.

7.

Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.

Lawind MF, Alyasky A, Elwan NM, Mourad H, Al-Bendary A.

Egypt J Immunol. 2004;11(1):75-81.

PMID:
15724389
8.
9.

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.

Brito-Zerón P, Gheitasi H, Retamozo S, Bové A, Londoño M, Sánchez-Tapias JM, Caballero M, Kostov B, Forns X, Kaveri SV, Ramos-Casals M.

Arthritis Res Ther. 2015 Sep 10;17:250. doi: 10.1186/s13075-015-0766-3.

10.
11.
12.

Immunologically restricted and inhibitory anti-Ro/SSA in monozygotic twins.

Scofield RH, Kurien BT, Reichlin M.

Lupus. 1997;6(4):395-8.

PMID:
9175026
13.

Immunological profiles determine neurological involvement in Sjögren's syndrome.

Jamilloux Y, Magy L, Hurtevent JF, Gondran G, de Seze J, Launay D, Ly KH, Lambert M, Hachulla E, Hatron PY, Vidal E, Fauchais AL.

Eur J Intern Med. 2014 Feb;25(2):177-81. doi: 10.1016/j.ejim.2013.10.005. Epub 2013 Oct 29.

PMID:
24176941
14.

Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.

Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, Yamagata H, Arnett FC.

Arthritis Rheum. 1986 Feb;29(2):196-206.

PMID:
3485431
15.

Lupus/Sjögren's autoantibody specificities in sera with paraproteins.

Sestak AL, Harley JB, Yoshida S, Reichlin M.

J Clin Invest. 1987 Jul;80(1):138-44.

16.

HTLV-I associated Sjögren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren's syndrome.

Hida A, Kawabe Y, Kawakami A, Migita K, Tominaga M, Nakamura H, Eguchi K.

Ann Rheum Dis. 1999 May;58(5):320-2.

17.

Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome.

Ben-Chetrit E, Fischel R, Rubinow A.

Clin Rheumatol. 1993 Dec;12(4):471-4.

PMID:
8124907
18.

HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome.

Bolstad AI, Wassmuth R, Haga HJ, Jonsson R.

J Rheumatol. 2001 Jul;28(7):1554-62.

PMID:
11469461
19.

The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies.

Ben-Chetrit E.

Br J Rheumatol. 1993 May;32(5):396-402. Review.

PMID:
8495261
20.

Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjögren's syndrome.

Beer RG, Rischmueller M, Coates T, Purcell AW, Keech CL, McCluskey J, Gordon TP.

Clin Immunol Immunopathol. 1996 Jun;79(3):314-8.

PMID:
8635291

Supplemental Content

Support Center